🇺🇸 FDA
Pipeline program

elafibranor, Placebo tablet

CLIN-60190-454

Phase 3 small_molecule active

Quick answer

elafibranor, Placebo tablet for Primary Biliary Cholangitis is a Phase 3 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Ipsen Pharma
Indication
Primary Biliary Cholangitis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials